Safety and Efficacy of an Ophthalmic Solution in Dry Eye Disease
- First Posted Date
- 2008-09-25
- Last Posted Date
- 2020-09-14
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 38
- Registration Number
- NCT00758784
- Locations
- 🇺🇸
ISTA Pharmaceuticals, Inc., Irvine, California, United States
Ocular Responses to Short and Long-term Lens Wear
Not Applicable
Completed
- Conditions
- Ametropia
- Interventions
- Device: Purevision Lenses with ReNu MultiplusDevice: Purevision Lenses with Optifree RepleniSH
- First Posted Date
- 2008-07-28
- Last Posted Date
- 2019-11-26
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 30
- Registration Number
- NCT00722891
- Locations
- 🇨🇦
University of Waterloo, Waterloo, Ontario, Canada
Evaluation of a Multi-Purpose Solution
Not Applicable
Completed
- Conditions
- Contact Lens Solutions
- Interventions
- Device: Bausch & Lomb Multi-Purpose Solution
- First Posted Date
- 2008-07-08
- Last Posted Date
- 2011-12-13
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 180
- Registration Number
- NCT00710879
- Locations
- 🇺🇸
Dr. Nicholas Marsico, Torrance, California, United States
Safety and Efficacy of Zylet vs Lotemax, Tobramycin and Vehicle in Pediatric Blepharoconjunctivitis
Phase 4
Completed
- Conditions
- Conjunctivitis
- Interventions
- Drug: Vehicle of Zylet
- First Posted Date
- 2008-06-25
- Last Posted Date
- 2015-03-24
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 137
- Registration Number
- NCT00705159
- Locations
- 🇺🇸
Pediatric Ophthalmology of Erie, Erie, Pennsylvania, United States
Efficacy and Safety of Bromfenac Ophthalmic Solution in Cataract Surgery
- First Posted Date
- 2008-06-24
- Last Posted Date
- 2013-01-18
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 156
- Registration Number
- NCT00704418
- Locations
- 🇺🇸
ISTA Pharmaceuticals, Inc., Irvine, California, United States
Efficacy and Safety of Bromfenac Ophthalmic Solution in Cataract Surgery
- First Posted Date
- 2008-06-24
- Last Posted Date
- 2015-03-24
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 126
- Registration Number
- NCT00703781
- Locations
- 🇺🇸
ISTA Pharmaceuticals, Inc., Irvine, California, United States
Study of T-PRED(TM) Compared to Pred Forte(R)
- First Posted Date
- 2008-06-18
- Last Posted Date
- 2020-09-25
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 64
- Registration Number
- NCT00699803
- Locations
- 🇺🇸
ISTA Pharmaceuticals, Inc., Irvine, California, United States
Loteprednol Etabonate in an Ophthalmic Base vs Vehicle for the Treatment of Inflammation Following Cataract Surgery
Phase 3
Completed
- Conditions
- Ocular Inflammation
- Interventions
- First Posted Date
- 2008-06-17
- Last Posted Date
- 2015-03-24
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 400
- Registration Number
- NCT00699153
- Locations
- 🇺🇸
Cornerstone Eye Wear, High Point, North Carolina, United States
Efficacy Study of Ecabet Ophthalmic Solution in Dry Eye Disease
- First Posted Date
- 2008-04-25
- Last Posted Date
- 2020-09-03
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 183
- Registration Number
- NCT00667004
- Locations
- 🇺🇸
ISTA Pharmaceuticals, Inc., Irvine, California, United States
Comparative Performance of PureVision Lens Designs
Phase 3
Completed
- Conditions
- Myopia
- Interventions
- Device: Currently Marketed PureVision Contact Lens.Device: Alternate Design of the PureVision Contact Lens.
- First Posted Date
- 2008-04-18
- Last Posted Date
- 2011-12-12
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 206
- Registration Number
- NCT00661687
- Locations
- 🇲🇾
Laser Focus Sdn Bhd, Vision Correction Centre, Johor Bahru, Malaysia
🇵🇭Asian Eye Institute, Makati City, Philippines
© Copyright 2025. All Rights Reserved by MedPath